|
Jul 26
|
Bio-Rad Laboratories, Inc. (BIO) Launches New Digital PCR Systems in 2025
|
|
Jul 24
|
Earnings Preview: Bio-Rad Laboratories (BIO) Q2 Earnings Expected to Decline
|
|
Jul 17
|
Bio-Rad to Report Second Quarter 2025 Financial Results on Thursday, July 31, 2025
|
|
Jul 16
|
Saudi Arabia In-Vitro Diagnostics Market Report 2025-2030 Featuring Abbott, BD, Bio-Rad Laboratories, Biomerieux, Danaher, Nihon Kohden, Roche, Siemens Healthineers, Sysmex, Thermo Fischer Scientific
|
|
Jul 14
|
Bio-Rad Stock Climbs Following the Launch of Four ddPCR Platforms
|
|
Jul 11
|
Ultrasensitive Molecular Amplification Market Research 2025-2035 | Demand Surges for Early Detection, Molecular Amplification Techniques Lead the Way
|
|
Jul 10
|
New Strong Sell Stocks for July 10th
|
|
Apr 15
|
Bio-Rad to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
|
|
Apr 4
|
Further weakness as Bio-Rad Laboratories (NYSE:BIO) drops 5.0% this week, taking three-year losses to 61%
|
|
Mar 31
|
Bio-Techne Opens New Customer Experience Centre in Germany
|
|
Mar 31
|
Charles River & Valo Health's Logica Identifies New Lupus Drug Candidate
|
|
Feb 26
|
Bio-Rad (BIO) International Revenue Performance Explored
|
|
Feb 25
|
HSIC Q4 Earnings Match Estimates, Margins Up, Stock Falls in Premarket
|
|
Feb 25
|
Veracyte Stock Falls Despite Q4 Earnings and Revenue Beat
|
|
Feb 18
|
Medtronic Q3 Earnings Top Estimates, Revenues Miss, Stock Tumbles
|
|
Feb 18
|
BIO Stock Might Rise Following the Offer to Acquire Stilla
|
|
Feb 17
|
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
|
|
Feb 15
|
Bio-Rad price target lowered to $447 from $477 at RBC Capital
|
|
Feb 15
|
Bio-Rad Laboratories Full Year 2024 Earnings: EPS Misses Expectations
|
|
Feb 14
|
BIO Q4 Earnings and Revenues Miss Estimates, Stock Down Aftermarket
|